📰 Linkedin News
Page 1066 - Linkedin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Linkedin. Real-time updates on events, politics, business and more.
April 10, 2024
Bengaluru techie Namrata Singh shares firsthand insights into Swiggys delivery process after a day as a delivery agent. Her LinkedIn post reveals key observations on order acceptance, workflow, and earnings transparency. Singh highlights the apps detailed tracking, safety features, and the dedication of delivery agents. Her immersive storytelling earns praise for shedding light on the behind-the-scenes dynamics of food delivery.
April 10, 2024
10.04.2024 - ^ Original-Research: Rubean AG - from NuWays AG Classification of NuWays AG to Rubean AG Company Name: Rubean AG ISIN: DE0005120802 Reason for the research: Update Recommendation: Kaufen Target price: EUR 9.00 Target price on sight of: ...
April 10, 2024
Africas Agrifood Entrepreneurs Called to Action: Applications Open for the US$100,000 GoGettaz Agripreneur Prize Competition
April 10, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 1, 2024, at...
April 10, 2024
Active Android spyware campaign 'eXotic Visit' targeting users in India and Pakistan.
April 10, 2024
Amid poor IIT-Bombay placement, a Microsoft techie advised job seekers to learn skills and do their best and assured them that their efforts would be rewarded. | Trending
April 10, 2024
It’s not the first time a CJI has attempted to fix a major reason that contributes to case pendency. The practice of reserving judgments for months beyond stipulated periods, where judges put off announcing their...
April 10, 2024
Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.
April 10, 2024
Amid news of sub-par placements even at top-tier engineering colleges, students are worrying about their futureExperts advise preparing for the worst and acquiring
April 10, 2024
OCALA, Fla., April 10, 2024 -- AIM ImmunoTech Inc. today announced top-line interim data indicating that combining Ampligen with Keytruda in the treatment of recurrent ovarian cancer may have...